PL384446A1 - Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method - Google Patents
Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production methodInfo
- Publication number
- PL384446A1 PL384446A1 PL384446A PL38444608A PL384446A1 PL 384446 A1 PL384446 A1 PL 384446A1 PL 384446 A PL384446 A PL 384446A PL 38444608 A PL38444608 A PL 38444608A PL 384446 A1 PL384446 A1 PL 384446A1
- Authority
- PL
- Poland
- Prior art keywords
- methyl
- tiazolidynodion
- pyridinamino
- ethoxy
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL384446A PL384446A1 (en) | 2008-02-12 | 2008-02-12 | Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method |
PCT/PL2009/000015 WO2009102226A1 (en) | 2008-02-12 | 2009-02-11 | Malonic acid salt of 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- 2,4-thiazolidinedione |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL384446A PL384446A1 (en) | 2008-02-12 | 2008-02-12 | Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method |
Publications (1)
Publication Number | Publication Date |
---|---|
PL384446A1 true PL384446A1 (en) | 2009-08-17 |
Family
ID=40810587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL384446A PL384446A1 (en) | 2008-02-12 | 2008-02-12 | Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL384446A1 (en) |
WO (1) | WO2009102226A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (en) | 2010-03-03 | 2011-09-09 | Sanofi | Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013068486A1 (en) | 2011-11-08 | 2013-05-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of male infertility |
CN109053717B (en) * | 2018-08-09 | 2022-05-31 | 天津理工大学 | Rosiglitazone gentisate and preparation method thereof |
CN109053718B (en) * | 2018-08-09 | 2022-06-03 | 天津理工大学 | Rosiglitazone saccharin salt and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0306228B1 (en) * | 1987-09-04 | 1999-11-17 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
WO2003053962A1 (en) * | 2001-12-20 | 2003-07-03 | Smithkline Beecham Plc | 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus |
CZ298424B6 (en) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Crystallization process of rosiglitazone and derivatives thereof from mixed solutions |
-
2008
- 2008-02-12 PL PL384446A patent/PL384446A1/en not_active Application Discontinuation
-
2009
- 2009-02-11 WO PCT/PL2009/000015 patent/WO2009102226A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009102226A1 (en) | 2009-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL384446A1 (en) | Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method | |
IL266563A (en) | Heterocyclic compounds useful as pdk1 inhibitors | |
HK1183875A1 (en) | Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl]-4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl]-n- [2-oxo-2- [ ( 2, 2, 2 - trifluoroethyl) amino]ethyl]-1- naphthalenecarboxamide 4-[5-[3--5-()]-45--5-()-3-]-n-[2-- 2-[(222-)]]-1- | |
IL216349A (en) | 4-(1-carboxy-ethylcarbamoyl)-4-(5-[1,2]dithiolan-3-yl-pentanoylamino)-butyric acid derivatives and compositions comprising them | |
IL207854A0 (en) | Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol | |
ZA201103033B (en) | Thioamide compounds, method of making and method of using thereof | |
IL247136B (en) | Compounds for reducing uric acid and uses thereof | |
ZA201303253B (en) | Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-yl-thio)acetic acid and uses thereof | |
ME02307B (en) | Crystalline (r)-(e)-2-(4-(2-(5-(1-(3,5-dichloropyrtdtn-4-yl)ethoxy)-1h-indazol- | |
HK1162516A1 (en) | (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as dgat inhibitors | |
IL220211A (en) | Process for the preparation of 1-(alkyl/phenyl/pyrid-2-yl)-5-pyrazolecarboxylic acid derivatives and intermediates obtained in said process | |
IL212070A (en) | Phenyl and pyridyl derivatives of 7-piperidinoalkyl-3,4-dihydroquinolone | |
HK1164856A1 (en) | Polymorphic forms of 3-(1-3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin- 2-yl]-benzyl-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof 3-(1-3-[5-(1---4-)--2-]--6--16--- 3-)- | |
EP2381772A4 (en) | Process and intermediates for the preparation of n-acylated-4-aryl beta-amino acid derivatives | |
HK1189591A1 (en) | Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidi-1-v-5-methyl-2 2- diphenylhexanamide 5-[3-(3-)-1-]-5--22- | |
IL208834A0 (en) | Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters | |
IL207431A0 (en) | New process for the preparation of cyclohexanecarboxylic acid derivatives | |
EP2304506A4 (en) | Toner having multiple inflection points on storage modulus curve with respect to temperature and method of preparing the same | |
EP2305673A4 (en) | Crystal of thiazolidinedione compound, and process for production thereof | |
IL213599A0 (en) | Improved biocatalysts for manufacturing duloxetine alcohol | |
PL385697A1 (en) | Salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]-2, 4-thiazolidinedione with 1, 5 naphtalene disulfonic acid, and method of its manufacturing | |
EP2332923A4 (en) | 5-[2-(methylthio)ethoxy] and pyrimidine-2-amine manufacturing method | |
PL385222A1 (en) | New N-[2-(alkoxycarbonyl)ethyl]-N-methyl-1-amine-1-deoxy-D-glucitola salts and method of their manufacturing | |
PL392673A1 (en) | Copolymers of photochromic 4-[(E)-[4-[(5-methylisoxazole-3-yl) sulphamoyl]phenyl]azo]phenyl methacrylate and process for the preparation thereof | |
PL392674A1 (en) | Photochromic copolymers of 4-[(E)-[4-[(5-methylisoxazole-3-yl) sulphamoyl]phenyl]azo]phenyl methacrylate and process for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |